Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
Saman Farahmand, Aileen I. Fernandez, F. Ahmed, D. Rimm, Jeffrey H. Chuang, Emily S. Reisenbichler, Kourosh Zarringhalam
Modern Pathology